There are 2789 resources available
1277P - Molecular features in young non-small cell lung cancer: A comparative analysis
Presenter: Tongmei Zhang
Session: ePoster Display
1278P - SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, as first-line therapy for PD-L1+ advanced/metastatic NSCLC: Data from a clinical expansion cohort of a phase I study
Presenter: Jifeng Feng
Session: ePoster Display
1279P - The prognostic value of chemotherapy-induced neutropenia (CIN) in patients with advanced non-small cell lung cancer (NSCLC) in the era of chemoimmunotherapy (CIT)
Presenter: Alexander Meisel
Session: ePoster Display
1280P - Sitravatinib + tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
Presenter: Qing Zhou
Session: ePoster Display
1282P - Biology of immune resistance in oncogenic driven advanced non-small cell lung cancer (aNSCLC)
Presenter: Mihaela Aldea
Session: ePoster Display
1283P - Predicting the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) by combining clinical and radiomic features
Presenter: Fariba Tohidinezhad
Session: ePoster Display
1358P - Phase I dose-escalation study to evaluate safety and clinical activity of c-MET inhibitor ABN401 in patients with advanced solid tumor
Presenter: Dae Ho Lee
Session: ePoster Display
1359TiP - RELATIVITY-104: First-line relatlimab (RELA) + nivolumab (NIVO) with chemotherapy vs nivo with chemotherapy in stage IV or recurrent non-small cell lung cancer (NSCLC): A phase II, randomized, double-blind study
Presenter: Daniel Morgensztern
Session: ePoster Display
1415P - Performance of a tumor-informed circulating tumor DNA assay from over 250 patients with over 600 plasma time points in esophageal and gastric cancer
Presenter: Brandon Huffman
Session: ePoster Display
1416P - Genomic landscape of late-stage gastric cancer
Presenter: Yelena Janjigian
Session: ePoster Display